DOW JONES NEWSWIRES
The Food and Drug Administration is set to announce Tuesday it will allow the temporary importation of a drug made by an Indian company to help offset a shortage of Johnson & Johnson's (JNJ) cancer drug Doxil, USA Today reported Monday on its website, citing an official with the agency.
The importation of Lipodox, made by Sun Pharma Global, will deal with the shortage of Doxil "for the foreseeable future," the FDA's Sandra Kweder said in an interview.
Doxil is used to treat patients with ovarian cancer and other tumors.
Full story at: http://yourlife.usatoday.com/health/story/2012-02-20/New- source-found-for-cancer-drug-Doxil-in-short-supply/53181806/1